UK's Trogenix raises £70m for cancer immunotherapy platform Edinburgh-based Trogenix has raised £70m to fund clinical trials of its triple-acting immunotherapies for brain and colorectal cancers.

#biotech #Trogenix #glioblastoma #GBM #4BIOCapital #drugdiscoveryplatform #Odysseus #syntheticsuperenhancers #SSEs #viralimmunotherapies #therapeuticpayloads #IL12 #AAV #SeriesAfinancing #Odysseusplatform #UKbiotechsector #venturecapitalinvestment #BIA #biotechfinancing
zurl.co/J20il

UK's Trogenix raises £70m for cancer immunotherapy platform Edinburgh-based Trogenix has raised £70m to fund clinical trials of its triple-acting immunotherapies for brain and colorectal cancers.

Edinburgh, #Scotland-based start-up #Trogenix has raised £70 million ($95 million) for a pipeline of therapies for hard-to-treat aggressive #cancer, starting with #glioblastoma. #financing

pharmaphorum.com/news/uks-tro...

Viralgen Partners with Trogenix to Propel AAV Gene Therapy for Glioblastoma Viralgen joins forces with Trogenix to advance AAV gene therapy for glioblastoma, enhancing manufacturing and accelerating clinical trials.

Viralgen Partners with Trogenix to Propel AAV Gene Therapy for Glioblastoma #Spain #San_Sebastián #Viralgen #AAV_Gene_Therapy #Trogenix